Author details

Full Name

Helen Farrugia

Affiliation

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
31869446	Think before you shave: Factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management.	Australasian Journal of Dermatology	2020
32356140	Differences in cancer survival by remoteness of residence: an analysis of data from a population-based cancer registry.	Cancer Causes and Control	2020
31999795	Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data.	PLoS ONE	2020
31328802	The increasing use of shave biopsy for diagnosing invasive melanoma in Australia.	Medical Journal of Australia	2019
30639877	Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.	Cancer Epidemiol	2019
29236346	Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.	Internal Medicine Journal	2018
30311110	Correction to: Differences in cancer survival by sex: a population-based study using cancer registry data.	Cancer Causes Control	2018
30194549	Differences in cancer survival by sex: a population-based study using cancer registry data.	Cancer Causes Control	2018
29717421	Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.	Annals of Surgical Oncology	2018
29363225	Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetings.	ANZ Journal of Surgery	2018
26435297	Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.	Hepatology	2016
25669479	Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years.	Medical Journal of Australia	2015
24643720	Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study.	Cancer	2014
21761352	The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics.	Horm Cancer	2010
19460066	Linking data from hospital and cancer registry databases: should this be standard practice?	Internal Medicine Journal	2010
20141433	Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.	Leukemia and Lymphoma	2010
20044859	Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer.	J Womens Health (Larchmt)	2009
19221894	The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer.	Fam Cancer	2009
19203322	Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia.	Medical Journal of Australia	2009
19453875	The incidence of invasive breast cancer among women prescribed testosterone for low libido.	J Sex Med	2009
18454846	Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer.	BMC Cancer	2008
10572844	Monitoring interval cancers in an Australian mammographic screening programme.	Journal of Medical Screening	1999
8847136	Childhood cancer in Victoria, Australia, 1970-1989.	International Journal of Cancer	1995
8309502	Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: patterns of incidence and survival.	Neuroepidemiology	1993
1828980	Cancer registration in Victoria, Australia, 1982-1987.	European Journal of Cancer	1991